47
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          Is there an association between ambient air pollutants and progression of emphysema and changes in lung function in the general population?

          Findings

          In this cohort study conducted between 2000 and 2018 that included 5780 participants in 6 US metropolitan regions followed up for a median of 10 years, there was a statistically significant association between baseline ambient concentrations of ambient ozone (O 3), fine particulate matter (PM 2.5), oxides of nitrogen (NO x), and black carbon with greater increases in emphysema assessed quantitatively using computed tomographic (CT) imaging. Concentrations of O 3 and NO x, but not concentrations of PM 2.5, over study follow-up were also associated with increases in emphysema. Baseline ambient O 3 was significantly associated with a faster decline in forced expiratory volume in the first second (FEV 1).

          Meaning

          Long-term exposure to ambient air pollutants, especially O 3, was significantly associated with increasing emphysema assessed quantitatively using CT imaging and with worsening lung function.

          Abstract

          Importance

          While air pollutants at historical levels have been associated with cardiovascular and respiratory diseases, it is not known whether exposure to contemporary air pollutant concentrations is associated with progression of emphysema.

          Objective

          To assess the longitudinal association of ambient ozone (O 3), fine particulate matter (PM 2.5), oxides of nitrogen (NO x), and black carbon exposure with change in percent emphysema assessed via computed tomographic (CT) imaging and lung function.

          Design, Setting, and Participants

          This cohort study included participants from the Multi-Ethnic Study of Atherosclerosis (MESA) Air and Lung Studies conducted in 6 metropolitan regions of the United States, which included 6814 adults aged 45 to 84 years recruited between July 2000 and August 2002, and an additional 257 participants recruited from February 2005 to May 2007, with follow-up through November 2018.

          Exposures

          Residence-specific air pollutant concentrations (O 3, PM 2.5, NO x, and black carbon) were estimated by validated spatiotemporal models incorporating cohort-specific monitoring, determined from 1999 through the end of follow-up.

          Main Outcomes and Measures

          Percent emphysema, defined as the percent of lung pixels less than −950 Hounsfield units, was assessed up to 5 times per participant via cardiac CT scan (2000-2007) and equivalent regions on lung CT scans (2010-2018). Spirometry was performed up to 3 times per participant (2004-2018).

          Results

          Among 7071 study participants (mean [range] age at recruitment, 60 [45-84] years; 3330 [47.1%] were men), 5780 were assigned outdoor residential air pollution concentrations in the year of their baseline examination and during the follow-up period and had at least 1 follow-up CT scan, and 2772 had at least 1 follow-up spirometric assessment, over a median of 10 years. Median percent emphysema was 3% at baseline and increased a mean of 0.58 percentage points per 10 years. Mean ambient concentrations of PM 2.5 and NO x, but not O 3, decreased substantially during follow-up. Ambient concentrations of O 3, PM 2.5, NO x, and black carbon at study baseline were significantly associated with greater increases in percent emphysema per 10 years (O 3: 0.13 per 3 parts per billion [95% CI, 0.03-0.24]; PM 2.5: 0.11 per 2 μg/m 3 [95% CI, 0.03-0.19]; NO x: 0.06 per 10 parts per billion [95% CI, 0.01-0.12]; black carbon: 0.10 per 0.2 μg/m 3 [95% CI, 0.01-0.18]). Ambient O 3 and NO x concentrations, but not PM 2.5 concentrations, during follow-up were also significantly associated with greater increases in percent emphysema. Ambient O 3 concentrations, but not other pollutants, at baseline and during follow-up were significantly associated with a greater decline in forced expiratory volume in 1 second per 10 years (baseline: 13.41 mL per 3 parts per billion [95% CI, 0.7-26.1]; follow-up: 18.15 mL per 3 parts per billion [95% CI, 1.59-34.71]).

          Conclusions and Relevance

          In this cohort study conducted between 2000 and 2018 in 6 US metropolitan regions, long-term exposure to ambient air pollutants was significantly associated with increasing emphysema assessed quantitatively using CT imaging and lung function.

          Abstract

          This cohort study examines the association between long-term exposure to ambient ozone, black carbon, and other air pollutants and progression of CT-defined percent emphysema and decline in lung function in adults in 6 US metropolitan regions.

          Related collections

          Author and article information

          Journal
          JAMA
          JAMA
          JAMA
          JAMA
          American Medical Association
          0098-7484
          1538-3598
          13 August 2019
          13 August 2019
          13 February 2020
          : 322
          : 6
          : 546-556
          Affiliations
          [1 ]Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle
          [2 ]Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, New York
          [3 ]Research and Education in Energy, Environment and Water Institute, University at Buffalo, Buffalo, New York
          [4 ]Department of Medicine, Columbia University Medical Center, New York, New York
          [5 ]Department of Environmental Health Sciences, Epidemiology, Mailman School of Public Health; Columbia University, New York, New York
          [6 ]RAND Corporation, Arlington, Virginia
          [7 ]Department of Radiology, University of Iowa, Iowa City
          [8 ]Department of Biomedical Engineering, Columbia University, New York, New York
          [9 ]Department of Environmental Health, Boston University School of Public Health, Boston, Massachusetts
          [10 ]Department of Statistics, University of Washington, Seattle
          [11 ]Department of Biostatistics, School of Public Health, University of Washington, Seattle
          [12 ]Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor
          [13 ]Department of Medicine, McGill University Health Centre, Montréal, Canada
          [14 ]Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York
          [15 ]Department of Epidemiology, School of Public Health, Drexel University, Philadelphia, Pennsylvania
          [16 ]Departments of Medicine and Epidemiology, University of Washington, Seattle
          Author notes
          Article Information
          Corresponding Author: Joel D. Kaufman, MD, MPH, University of Washington, Box 354695, 4225 Roosevelt Way NE, Ste 100, Seattle, WA 98105 ( joelk@ 123456uw.edu ).
          Accepted for Publication: June 24, 2019.
          Author Contributions: Drs Kaufman and Barr had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. The first authorship roles were shared by Drs Wang, Aaron, and Madrigano and last authorship roles were shared by Drs Kaufman and Barr.
          Concept and design: Wang, Hoffman, Kinney, Sheppard, Smith, Vedal, Kaufman, Barr.
          Acquisition, analysis, or interpretation of data: Wang, Aaron, Madrigano, Hoffman, Angelini, Yang, Laine, Vetterli, Sampson, Sheppard, Szpiro, Adar, Smith, Kirwa, Lederer, Diez Roux, Vedal, Kaufman, Barr.
          Drafting of the manuscript: Wang, Laine, Vedal, Kaufman, Barr.
          Critical revision of the manuscript for important intellectual content: All authors.
          Statistical analysis: Wang, Aaron, Madrigano, Angelini, Yang, Laine, Sampson, Szpiro, Adar, Kirwa, Vedal, Kaufman, Barr.
          Obtained funding: Hoffman, Smith, Kaufman, Barr.
          Administrative, technical, or material support: Wang, Hoffman, Angelini, Yang, Laine, Vetterli, Smith, Kirwa, Lederer, Kaufman.
          Supervision: Hoffman, Laine, Smith, Lederer, Vedal, Kaufman.
          Conflict of Interest Disclosures: Dr Wang reported receiving grants from University of Washington (US EPA RD831697, US EPA RD83479601-01, NIEHS K24ES013195, NIEHS P30ES07033) during the conduct of the study. Dr Aaron reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study, grants from the Stony Wold-Herbert Fund and the Alpha1 Foundation, and personal fees from Lancet Respiratory Medicine outside the submitted work. Dr Madrigano reported receiving grants from National Oceanic and Atmospheric Administration during the conduct of the study and personal fees from the NIH outside the submitted work. Dr Hoffman reported receiving grants from the NIH; is a founder and shareholder of VIDA Diagnostics, a company commercializing lung image analysis software developed, in part, at the University of Iowa; and holds patents for an apparatus for analyzing CT images to determine the presence of pulmonary tissue pathology (US6466687B1), an apparatus for image display and analysis (WO1990016056A1), and a method for multiscale meshing of branching biological structures (US20110093243A1). Dr Yang reported receiving grants from the NIH (NIH R01-HL121270) during the conduct of the study. Dr Sampson reported receiving grants from the EPA (RD831697, RD83479601-01) during the conduct of the study. Dr Sheppard reported receiving grants from the EPA during the conduct of the study and grants from the NIH and personal fees from the Health Effects Institute outside the submitted work. Dr Szpiro reported receiving grants from the EPA and the National Institute of Environmental Health Sciences during the conduct of the study and personal fees from Health Effects Institute and the Electric Power Research Institute outside the submitted work. Dr Smith reported receiving grants from the NIH during the conduct of the study and grants from Quebec Health Research Fund, AstraZeneca, and McGill University Health Center Research Institute outside the submitted work. Dr Lederer reported receiving personal fees from Roche, Sanofi Genzyme, Philips Respironics, Fibrogen, Global Blood Therapeutics, Boehringer-Ingelheim, Veracyte, and Galapagos outside the submitted work; institutional grant support from Fibrogen, Global Blood Therapeutics, and Boehringer-Ingelhim; performing unpaid consulting work for Galecto, Pliant Therapeutics, and Bristol-Myers Squibb; and is now a full-time employee of Regeneron Pharmaceuticals (but was a was a full-time employee of Columbia University during the conduct of the study). Dr Diez-Roux reported receiving grants from the EPA and the NIH during the conduct of the study and Wellcome Trust outside the submitted work. Dr Kaufman reported receiving grants from the EPA and the NIH during the conduct of the study and the US National Institutes for Occupational Safety and Health, the Health Effects Institute, the Kresge Foundation, and the Global Alliance for Clean Cookstoves outside the submitted work. Dr Vedal reported receiving grants from the EPA during the conduct of the study and support for a research chair from AXA Research Fund outside the submitted work. Dr Barr reported receiving grants from the COPD Foundation and the Alpha1 Foundation outside the submitted work and grants from the EPA and NIH during the conduct of the study. No other disclosures were reported.
          Funding/Support: This article was developed under a STAR research assistance agreement, No. RD831697 (MESA Air) and RD-83830001 (MESA Air Next Stage), awarded by the US Environmental Protection Agency (EPA) and the University of Washington Center for Clean Air Research (UW CCAR, EPA RD83479601-01). It has not been reviewed by the EPA. The MESA Lung Study was funded by the National Institutes of Health/National Heart, Lung, and Blood Institute grants R01-HL077612, RC1-HL100543, R01-HL093081, R01-HL121270, and R01-HL130605. MESA was funded by National Institutes of Health/ National Heart, Lung, and Blood Institute contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, and N01-HC-95169 and by grants UL1-TR-000040 and UL1-TR-001079 from NCRR; the work was also supported by grants K24ES013195, P30ES07033, and R01ES023500 from the National Institute of Environmental Health Sciences.
          Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
          Disclaimer: The views expressed in this article are solely those of the authors and the EPA does not endorse any products or commercial services mentioned in this publication.
          Additional Contributions: The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.
          Article
          PMC6692674 PMC6692674 6692674 joi190076
          10.1001/jama.2019.10255
          6692674
          31408135
          8824a543-3c84-4a8f-97ee-55c3bb1aad26
          Copyright 2019 American Medical Association. All Rights Reserved.
          History
          : 19 November 2018
          : 24 June 2019
          Funding
          Funded by: US Environmental Protection Agency
          Funded by: University of Washington Center for Clean Air Research
          Funded by: National Institutes of Health/National Heart, Lung, and Blood Institute
          Funded by: National Institutes of Health
          Funded by: National Heart, Lung, and Blood Institute
          Funded by: National Institute of Environmental Health Sciences
          Categories
          Research
          Research
          Original Investigation

          Comments

          Comment on this article